Clinical trials: Wound Cleansing

Wound Heal

Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.

• Completed
• Age: 22 years and older
• Medical device
• Results posted

A randomized, open-label, investigational safety evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) device as a volumetric biomaterial scaffold applied to clean wounds after skin cancer surgery with Mohs…

Trial name

MOSAIC (NCT06600152)

Testing

MAP Wound Matrix, DuoDerm

Where

3 sites in United States

Volunteers

40 people

Sponsor

Tempo Therapeutics